Catalyst Biosciences Expands its Protease Medicines Patent Portfolio of Complement Factor 3 Degraders
SOUTH SAN FRANCISCO, Calif., April 12, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent Number 10,954,501 B2 entitled “Nucleic Acid Encoding Modified Membrane Type Serine Protease 1...
HCI Group Sets First Quarter 2021 Earnings Call for Thursday, May 6, 2021 at 4:45 p.m. ET
TAMPA, Fla., April 12, 2021 (GLOBE NEWSWIRE) -- HCI Group, Inc. (NYSE:HCI), an InsurTech company with operations in insurance, software development and real estate, will hold a conference call on Thursday, May 6, 2021, at 4:45 p.m. Eastern time to discuss results for the first quarter ended March...
Tattooed Chef Expands Pizza Offering with the Launch of New Plant-Based Pizzas
PARAMOUNT, Calif., April 12, 2021 (GLOBE NEWSWIRE) -- Tattooed Chef, Inc. (Nasdaq: TTCF) (“Tattooed Chef” or the “Company”), a leader in plant-based foods, today announced it has expanded its pizza offering with the launch of five new plant-based pizzas. The 12 oz pizzas are certified plant-based,...
NuGenerex Immuno-Oncology Submits Protocol, Data, and Manufacturing Information to FDA in Advance of the IND Submission
Response to Pre-IND Comments Pre-clinical and ex-vivo results GMP Manufacturing Adjuvant data Revised protocol as per FDA recommendations MIRAMAR, Fla., April 12, 2021 (GLOBE NEWSWIRE) -- NuGenerex Immuno-Oncology (NGIO – www.nugenerexio.com), a subsidiary of Generex Biotechnology Corporation...
URBN Announces Personnel Changes and a Sales Update
PHILADELPHIA, April 12, 2021 (GLOBE NEWSWIRE) -- Urban Outfitters, Inc. (NASDAQ:URBN), earlier this morning announced a personnel change at the Anthropologie Group. Hillary Super has stepped down as Global Chief Executive Officer. Her last day was Friday, April 9th. We thank Hillary for her...
Amunix Presents Preclinical Data at American Academy of Cancer Research (AACR) Annual Meeting from Lead Program AMX-818 Demonstrating Robust Efficacy in HER2 Tumor Models and Enhanced Safety
AMX-818 is the lead program in Amunix’s XPAT® (XTENylated Protease-Activated T cell engager) platform designed to improve the toxicity profile of T cell engagers for the treatment of HER2-expressing solid tumors In vivo, preferential cleavage of AMX-818 was demonstrated in xenograft tumors...
Kenna Security Joins Microsoft Intelligent Security Association
SAN FRANCISCO, April 12, 2021 (GLOBE NEWSWIRE) -- Kenna Security, an enterprise leader in risk-based vulnerability management, has joined the Microsoft Intelligent Security Association (MISA) to optimize vulnerability management as part of a vibrant ecosystem of independent organizations dedicated...
Sterling National Bank Signs Banking as a Service Agreement with BrightFi
PEARL RIVER, N.Y., April 12, 2021 (GLOBE NEWSWIRE) -- Sterling National Bank, the wholly-owned operating bank subsidiary of Sterling Bancorp (NYSE: STL), today announced it has entered into a Banking as a Service agreement with BrightFi, a provider of cloud-based digital banking platform...
Vivos Therapeutics to Participate at the Emerging Growth Conference
HIGHLANDS RANCH, Colo., April 12, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate...
Harsco Corporation Announces Timing of First Quarter 2021 Results and Conference Call
CAMP HILL, Pa., April 12, 2021 (GLOBE NEWSWIRE) -- Harsco Corporation (NYSE: HSC) today announced that it will issue its first quarter 2021 earnings results on Tuesday, May 4, 2021 prior to NYSE market open via newswire distribution and a posting on the company website at www.harsco.com. The...